ArticleMolecular oncology2026

Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity.

Marco Strecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.